- Home
- Equipment
- south korea
- biomark
Show results for
Refine by
Biomark Equipment Supplied In South Korea
12 equipment items found
Manufactured by:IMB Dx, Inc. based inSeoul, SOUTH KOREA
AlphaLiquid®100 is a test that enables the detection of biomarkers which can predict the efficacy/resistance of targeted therapy for one blood test across 118 cancer-related genes. During cancer patients’ treatment journey, a simple blood draw can be used to support monitoring the treatment response and change the strategy when resistance biomarkers ...
Manufactured by:SD Biosensor based inSuwon-si, SOUTH KOREA
STANDARD M10 is a Point-of-Care MDx system that enables simple, fast and accurate diagnosis of infectious disease, drug resistance, and genetic ...
by:DEARGEN Inc. based inDaejeon, SOUTH KOREA
WX presents biomarkers, based on raw transcriptome data. It is an artificial intelligence technology that can predict biomarkers, prognostic biomarkers and even the mode of action (MOA) of disease ...
by:Theramx Inc. based inSeongnam-si, SOUTH KOREA
Technology that excavates biomarkers through an analysis of brainwaves in epilepsy or Alzheimer’s patients, predicts the likelihood of onset, or diagnoses the advance, based on the degree of change of brainwave biomarkers measured by a wearable EEG (AI-electroencephalogram) measuring instrument allowing. ...
Manufactured by:Boditech Med Inc. based inGangwon-do, SOUTH KOREA
Tn-I, CK-MB, and Myoglobin are secreted in blood after the heart gets injured by cardiac stress for the lack of oxygen. The levels of these biomarkers can reveal the degree of a heart attack or damage. It would test for the level of those biomarkers in the blood to assist clinicians to assess the cardiac health ...
Manufactured by:RapiGEN Inc. based inSuwon-si, SOUTH KOREA
Cotinine is an alkaloid chemical found in tobacco and is also the predominant metabolite of nicotine. Cotinine is used as a biomarker for smoking. Cotinine has approximate 20 hours of in vivo half-life so it can be detected in a few days (up to one week) after the use of tobacco. The level of cotinine in the blood, saliva and urine depends on amount of exposure to tobacco smoke, ...
by:Theramx Inc. based inSeongnam-si, SOUTH KOREA
Biosensing technology that enables early diagnosis and prevention of diseases through an analysis of complex causal substances (proteins, lipids, organic acids, etc.) for dementia or metabolic syndrome, etc., as well as analysis/detection of composite biomarkers utilizing AI technology. ...
Manufactured by:Boditech Med Inc. based inGangwon-do, SOUTH KOREA
The appearance of elevated CK-MB levels in serum is highly specific and sensitive for myocardial cell wall injury. Since it varies from one to another, other biomarkers such as Troponin I should be considered together with the CK-MB test to assess heart health. It provides solution to measure blood CK-MB level on a POC ...
by:DEARGEN Inc. based inDaejeon, SOUTH KOREA
UG is an AI platform for developing new drugs that is based on DEARGEN’s deep learning technology. It specializes in genome data analysis, biomarker prediction, molecule selection and optimization. DEARGEN discovers new disease targets with Dr.UG and further realizes precision medicine by designing small molecules for new ...
Manufactured by:IMB Dx, Inc. based inSeoul, SOUTH KOREA
AlphaLiquid® Detect is an industry-first tumor-informed, hybrid-capture NGS-based liquid biopsy test designed for MRD detection and recurrence monitoring in stage I-III solid tumor patients. The assay incorporates a personalized panel of up to 1,000 targets, including both tumor-informed patient-specific markers as well as additional therapeutic targets. By delivering exceptional detection ...
Manufactured by:GENCURIX based inGuro-gu, SOUTH KOREA
What is early diagnosis? Early diagnosis helps people to plan ahead while they are still able to make important decisions on their care and support needs and on financial and legal ...
Manufactured by:LISCure Biosciences Inc. based inSeongnam-si, SOUTH KOREA
The LMT (LISCure Microbiology-based Technology) platform is an innovative tool to keep discovering and analyzing microbial and genome-based drug candidates. LMT (LISCure Microbiology-based Technology) Platform Consists of the Therapeutic Screening Platform, Microbial Optimization Platform, and Microbiome Database ...